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Dear Editor,
Different autoimmune disorders can coexist in one patient, 
however concomitant idiopathic systemic lupus erythematosus 
(SLE) and Crohn’s disease (CD) is seldom (1,2). Even rarer is 
the association between lupus nephritis and CD, with only two 
cases reported to date (3,4). Overlapping diagnostic criteria for 
CD and SLE make the diagnosis, and treatment options, a real 
challenge (2,5). 
We report the case of a 34-year-old woman diagnosed with 
SLE at age 13 in the context of polyarthritis and nephritis. She 
was treated with cyclophosphamide and methylprednisolone 
and remission was achieved. In 2012 she was admitted to our 
department for abdominal pain, diarrhea (10-12 loose stools per 
day) and weight loss > 10 %, in the last six months prior to ad-
mission. She was under no treatment at the onset of symptoms. 
Physical examination showed tenderness in the hypochondrium 
and right flank. No clinical or laboratory evidence of a SLE 
flare-up was found. In laboratory tests, she had anemia (11 g/
dL), C-reactive protein more than 20 times normal and normal 
urinalysis. She had positive anti-CMV IgM (1,730 IU/mL, ≥ 1). 
Colonoscopy showed several deep pleomorphic ulcers, some 
confluent, with sparse normal mucosa between them, from the 
rectum to the cecum. The colon biopsies were compatible with 
Crohn’s disease and excluded CMV colitis, tuberculosis or vas-
culitis. The computed tomography enterography showed dif-
fuse concentric wall thickening from the cecum to the sigmoid 
colon associated with hypervascularization of the mesocolic 
adjacent fat. 
Treatment was started with i.v. corticosteroids, with partial 
improvement observed. Therefore, i.v. ganciclovir was added 
with no change in the clinical status seen after 72 hours. En-
doscopic review showed persistence of multiple pleomorphic 
ulcers. Histology was compatible with CD without identifying 
cytological stigmata of CMV infection.
Patient was subsequently treated with infliximab with a dra-
matic improvement of symptoms and laboratorial parameters. 
Azathioprine was later added. At present, with combined thera-
py, the patient is in clinical remission during a follow-up of 20 
months, without any evidence of a SLE flare-up.
Discussion
It is known that infliximab administration may induce a lu-
pus-like syndrome as a possible side effect (1-3,5). However in 
our case, using infliximab resulted in no flare-up of SLE with 
CD remission. Furthermore, in one of the two cases reported of 
lupus nephritis associated with CD, the therapeutic regimen with 
infliximab actually lead to a beneficial effect on both diseases 
(3). There are also occasional reports describing the efficacy of 
anti-TNFα therapy for SLE (5).
Owing to the rarity of the association and the complexity of 
diagnosis and treatment of these diseases, we believe sharing 
our experience of a positive outcome in such a delicate balance 
between benefits and possible side effects is of great relevance.
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